CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-22 | WALT DAVID R Director | Purchase | +4,500 | $2.24 | $10K | 89,103 |
| 2016-01-21 | WALT DAVID R Director | Purchase | +4,500 | $2.32 | $10K | 84,603 |
| 2016-01-20 | WALT DAVID R Director | Purchase | +4,500 | $2.35 | $11K | 80,103 |
| 2016-01-19 | WALT DAVID R Director | Purchase | +4,400 | $2.52 | $11K | 75,603 |
| 2016-01-15 | WALT DAVID R Director | Purchase | +4,172 | $2.42 | $10K | 71,203 |
| 2016-01-14 | WALT DAVID R Director | Purchase | +4,400 | $2.64 | $12K | 67,031 |
| 2016-01-13 | WALT DAVID R Director | Purchase | +4,384 | $2.69 | $12K | 62,631 |
| 2016-01-12 | WALT DAVID R Director | Purchase | +4,300 | $2.89 | $12K | 58,247 |
| 2016-01-11 | WALT DAVID R Director | Purchase | +4,355 | $2.86 | $12K | 53,947 |
| 2016-01-08 | WALT DAVID R Director | Purchase | +4,500 | $2.87 | $13K | 49,592 |
| 2016-01-07 | WALT DAVID R Director | Purchase | +4,300 | $2.87 | $12K | 45,092 |
| 2016-01-06 | WALT DAVID R Director | Purchase | +4,500 | $3.03 | $14K | 40,792 |
| 2016-01-05 | ONeill James E Principal Accounting Officer | Grant or award · Incentive Stock Option (right to buy) | +4,900 | 4,900 | ||
| 2016-01-05 | GUIFFRE CHRISTOPHERD T Chief Executive Officer | Grant or award · Incentive Stock Option (right to buy) | +137,000 | 137,000 | ||
| 2016-01-05 | Senderowicz Adrian SVP, Chief Medical Officer | Grant or award · Incentive Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-01-05 | Carvajal Alejandra VP, General Counsel | Grant or award · Incentive Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2016-01-05 | WALT DAVID R Director | Purchase | +4,301 | $3.06 | $13K | 36,292 |
| 2016-01-04 | WALT DAVID R Director | Purchase | +4,500 | $3.01 | $14K | 31,991 |
| 2015-12-31 | ONeill James E Principal Accounting Officer | Grant or award | +1,098 | $2.38 | $3K | 2,098 |
| 2015-12-31 | GUIFFRE CHRISTOPHERD T Chief Executive Officer | Grant or award | +2,757 | $2.38 | $7K | 2,757 |
Page 9 of 18 · 344 trades